TY - JOUR
T1 - Severe congenital neutropenia
T2 - Clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor
AU - Weston, Brent
AU - Todd, Robert F.
AU - Axtell, Richard
AU - Balazovich, Kenneth
AU - Stewart, Jeffrey
AU - Locey, Betty J.
AU - Mayo-Bond, Laura
AU - Loos, Paul
AU - Hutchinson, Raymond
AU - Boxer, Laurence A.
PY - 1991/4
Y1 - 1991/4
N2 - We studied neutrophil function and clinical responses in seven patients with severe congenital neutropenia (SCN) after they received treatment with recombinant human granulocyte colony stimulating factor (rhG-CSF). Two subpopulations of patients with SCN were defined by their pattern of absolute neutrophil response, superoxide production, and cytochrome b559 levels. One group had an oscillating absolute neutrophil count and reduced ability to produce superoxide and cytochrome b559 (n = 4), and the second group had a relatively constant absolute neutrophil count response with normal superoxide and cytochrome levels (n = 3). Neutrophils from both groups had decreased surface expression of FcRIII and abnormal upregulation of the C3bi receptor (CR3). All patient neutrophils, however, had normal contents of the primary granule constituent, β-glucuronidase, and the specific granule constituent, vitamin B 12 binding protein. The clinical response to rhG-CSF was evident by marked improvement in the degree of periodontitis and reduction in the number of oral ulcers in both groups of patients. Although neutrophil function is not completely normal in patients with SCN, it is likely that enough redundancy exists in neutrophil bactericidal capacity to promote normal host response to inflammation.
AB - We studied neutrophil function and clinical responses in seven patients with severe congenital neutropenia (SCN) after they received treatment with recombinant human granulocyte colony stimulating factor (rhG-CSF). Two subpopulations of patients with SCN were defined by their pattern of absolute neutrophil response, superoxide production, and cytochrome b559 levels. One group had an oscillating absolute neutrophil count and reduced ability to produce superoxide and cytochrome b559 (n = 4), and the second group had a relatively constant absolute neutrophil count response with normal superoxide and cytochrome levels (n = 3). Neutrophils from both groups had decreased surface expression of FcRIII and abnormal upregulation of the C3bi receptor (CR3). All patient neutrophils, however, had normal contents of the primary granule constituent, β-glucuronidase, and the specific granule constituent, vitamin B 12 binding protein. The clinical response to rhG-CSF was evident by marked improvement in the degree of periodontitis and reduction in the number of oral ulcers in both groups of patients. Although neutrophil function is not completely normal in patients with SCN, it is likely that enough redundancy exists in neutrophil bactericidal capacity to promote normal host response to inflammation.
UR - http://www.scopus.com/inward/record.url?scp=0025763416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025763416&partnerID=8YFLogxK
M3 - Article
C2 - 1707086
AN - SCOPUS:0025763416
SN - 0022-2143
VL - 117
SP - 282
EP - 290
JO - The Journal of Laboratory and Clinical Medicine
JF - The Journal of Laboratory and Clinical Medicine
IS - 4
ER -